| Myriad Genetics and Ultima Genomics to Explore the UG 100™ Sequencing Platform to Advance Clinical Test Offerings in Oncology and Reproductive Genomics | 10/03 09:00 | globenewswire.com |
| Myriad Genetics Announces Third Patent Granted for Molecular Residual Disease (MRD) with Early Priority Date | 10/01 16:05 | globenewswire.com |
| BMRN or MYGN: Which Is the Better Value Stock Right Now? | 10/01 12:46 | zacks.com |
| Here's Why Myriad Genetics (MYGN) is a Strong Momentum Stock | 09/18 10:56 | zacks.com |
| Should You Continue to Retain MYGN Stock in Your Portfolio? | 09/17 10:25 | zacks.com |
| New Partnerships to Aid Myriad Genetics Stock Amid Macro Issues | 09/04 12:41 | zacks.com |
| Why Myriad Genetics (MYGN) is a Top Momentum Stock for the Long-Term | 08/30 10:50 | zacks.com |
| Myriad Genetics to Participate in Two Upcoming Investor Healthcare Conferences | 08/21 08:00 | globenewswire.com |
| Myriad Genetics, Inc. (MYGN) Q2 2024 Earnings Call Transcript | 08/09 11:20 | seekingalpha.com |
| Myriad Genetics (MYGN) Q2 Earnings Surpass, '24 Outlook Raised | 08/08 09:21 | zacks.com |